• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 23, 2024 at 11:02: AM
via The US Food and Drug Administration (FDA) has granted clearance for Galapagos’ investigational new drug (IND) application to commence the Phase I/II ATALANTA-1 study of GLPG5101 for relapsed/refractory non-Hodgkin lymphoma (r/r NHL).

article source
 






Top Bottom
Back
Quote